News Related to Monoclonal Antibody Therapies

Related coverage linked through entity extraction aliases.

FDA Plans to Ease Biosimilar Testing Requirements as Market Expands

Mar 11, 2026

The FDA is expected to issue draft guidance reducing testing requirements for biosimilar drugs, potentially lowering development costs by USD 20 million. The move comes as the biosimilars market shows strong growth, with major launches in 2025.

Blood Biomarkers Advance Early Alzheimer's Detection With New Diagnostic Capabilities

Feb 16, 2026

Blood-based biomarkers including brain-derived tau and amyloid-beta are enabling earlier Alzheimer's disease diagnosis through non-invasive testing, though confirmatory imaging remains necessary before treatment initiation.